Haemonetics Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $253.6M | $739.6M | $139.6M |
| FY2018 | $59.4M | $752.4M | $180.2M |
| FY2019 | $322.5M | $667.9M | $169.4M |
| FY2020 | $305.5M | $587.1M | $137.3M |
| FY2021 | $690.6M | $731.7M | $192.3M |
| FY2022 | $559.4M | $749.4M | $259.5M |
| FY2023 | $754.1M | $818.0M | $284.5M |
| FY2024 | $797.6M | $960.0M | $178.8M |
| FY2025 | $921.2M | $820.8M | $306.8M |
| FY2026 | $1.22B | $796.3M | $245.4M |